BioSpace News Archive

Drug Development

Enobia Pharma Provides Update on Progress With ENB-0040, a Bone-Targeted Enzyme Replacement Therapy for Hypophosphatasia

September 8, 2010
·
4 min read
Silence Therapeutics plc Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics

September 8, 2010
·
5 min read
Drug Development

Cylene Pharmaceuticals, Inc.e to Report Recent Advances With First-in-Class CK2 Inhibitor, CX-4945, at International CK2 Conference

September 8, 2010
·
3 min read
Deals

NEXUS Biosystems, Inc. Completes Acquisition of REMP Sample Management Business From Tecan

September 8, 2010
·
2 min read
Pharm Country

NuGEN Technologies, Inc. Joins AMDeC’s Vendor Partnership Program

September 8, 2010
·
3 min read
Addex Pharmaceuticals Awarded Michael J. Fox Foundation Grant for ADX48621 to Treat Levodopa-Induced Dyskinesia in Parkinson’s Disease

September 8, 2010
·
3 min read
Suven Life Sciences Ltd Secures 8th Product Patent Both in Australia and Mexico

September 8, 2010
·
2 min read
Drug Development

Cempra Pharmaceuticals, Inc. Initiates Both a Phase 2 Study With an Oral Formulation and a Phase 1 Study of The Intravenous Formulation of Solithromycin (CEM-101), a Novel Fluoroketolide

September 8, 2010
·
5 min read
Drug Development

Antisoma PLC’s Phase III Trial of AS1413 Completes Patient Enrollment

September 8, 2010
·
3 min read
Genethon to Use Polyplus-Transfection’s Jetpei(TM) Transfection Reagent for Producing Viral Vectors

September 8, 2010
·
3 min read